https://scholars.lib.ntu.edu.tw/handle/123456789/528462
標題: | Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010 | 作者: | Toh H.-S. Chuang Y.-C. Huang C.-C. Lee Y.-L. Liu Y.-M. Ho C.-M. Lu P.-L. Liu C.-E. Chen Y.-H. Wang J.-H. Ko W.-C. Yu K.-W. Liu Y.-C. Chen Y.-S. Tang H.-J. PO-REN HSUEH |
公開日期: | 2012 | 卷: | 40 | 期: | SUPPL. 1 | 起(迄)頁: | S18-S23 | 來源出版物: | International Journal of Antimicrobial Agents | 摘要: | We investigated the trends in antimicrobial resistance among species of Gram-negative bacilli isolated from patients with hepatobiliary tract infections in Taiwan during the period 2006-2010 as part of the Study for Monitoring Antimicrobial Resistance Trends (SMART). During the study period, 1032 isolates of Gram-negative bacilli that had been collected from patients with hepatobiliary infections were tested for susceptibility to 12 antimicrobial agents in accordance with the Clinical and Laboratory Standards Institute guidelines. Enterobacteriaceae accounted for the majority (n = 874, 84.7) of isolates and Escherichia coli was the most common pathogen (n = 323, 31.3). There were significantly more E. coli (P = 0.001) and Proteus mirabilis (P = 0.031) isolates collected from patients who had been hospitalized for less than 48 h and significantly more Serratia marcescens (P = 0.035) and Pseudomonas aeruginosa (P = 0.008) isolates collected from patients who had been hospitalized for 48 h or longer. The prevalence of extended-spectrum β-lactamase (ESBL)-producing pathogens was low. The decline in susceptibility rates with time was remarkable for ceftazidime (P = 0.036), ciprofloxacin (P = 0.029), and levofloxacin (P = 0.018). The most effective antibiotics, i.e., those that were active against more than 90 of Enterobacteriaceae, were amikacin, cefepime, imipenem, ertapenem, and piperacillin-tazobactam. Susceptibility of P. aeruginosa to anti-pseudomonal agents was greater than 80. In this study, we found an overall increase in resistance to antimicrobial agents among Gram-negative bacilli isolated from patients with hepatobiliary tract infections in Taiwan. Surveillance of antimicrobial susceptibility and updates of treatment guidelines are recommended to help achieve optimal therapy for patients with hepatobiliary infections. ? 2012 Elsevier B.V. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/528462 | ISSN: | 0924-8579 | DOI: | 10.1016/S0924-8579(12)70005-5 | SDG/關鍵字: | amikacin; cefepime; cefoxitin; ceftazidime; ceftriaxone; ciprofloxacin; ertapenem; imipenem; levofloxacin; piperacillin plus tazobactam; sultamicillin; antibiotic resistance; antibiotic sensitivity; article; bacterium isolate; biliary tract infection; Escherichia coli; Gram negative bacterium; Klebsiella oxytoca; Klebsiella pneumoniae; nonhuman; priority journal; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Taiwan; Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gallbladder Diseases; Hospitalization; Humans; Liver Diseases; Microbial Sensitivity Tests; Ofloxacin; Population Surveillance; Practice Guidelines as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Taiwan; Time Factors |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。